In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Scentrex(R) DTS 1.20 sachet Drug Master File in Korea (Scentrex(R) DTS 1.20 sachet KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Scentrex(R) DTS 1.20 sachet. The MFDS reviews the Scentrex(R) DTS 1.20 sachet KDMF as part of the drug registration process and uses the information provided in the Scentrex(R) DTS 1.20 sachet KDMF to evaluate the safety and efficacy of the drug.
After submitting a Scentrex(R) DTS 1.20 sachet KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Scentrex(R) DTS 1.20 sachet API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Scentrex(R) DTS 1.20 sachet suppliers with KDMF on PharmaCompass.